Healthcare >> CEO Interviews >> September 8, 2008

Keith A. Katlin – Avanir Pharmaceuticals (avnr)

TWST: May we start with a brief history of your company as well as an overview

of your portfolio of products?

Mr. Katkin: AVANIR has been a publicly traded biopharmaceutical company since